News & Updates

Angiolutions strengthens intellectual property protection for
its early aortic aneurysm treatment: second US patent granted

Second US patent granted in May, first EU patent granted in July; Increasing total patent portfolio to 16 patents and applications; Intellectual property (IP) portfolio protects innovation from multiple angles

Angiolutions announces advisory board to accelerate early-stage treatment for abdominal aortic aneurysms

Angiolutions Advisory Board Members at a recent meeting in Germany
July 3, 2024 – Angiolutions announces its Advisory Board, comprising industry leaders, distinguished researchers, and clinicians from world-renowned institutions.

Angiolutions wins START HEALTHCARE competition

June 18, 2024 – Angiolutions won first place in the competition START HEALTHCARE which was held at the MedtecLIVE Tradefair in Stuttgart. 

Angiolutions secures €2.5 million European Innovation Council grant

July 27th, 2023, Angiolutions has been awarded the prestigious European Innovation Council (EIC) Accelerator Grant and will receive €2.5 million in funding for its groundbreaking treatment for early-stage abdominal aortic aneurysms.

Angiolutions wins Maxis CSI Innovator Award

December 10, 2022: Angiolutions has been honored with the Maxis CSI Innovator Award, acknowledging the company’s groundbreaking technology, remarkable potential for impact, robust IP strategy, and exceptional market potential in addressing abdominal aortic aneurysms.

Angiolutions receives ISO 13485 certification
for its fully digital quality management system​

As of December 22, 2021, Angiolutions is ISO 13485 certified. This ensures highest levels of quality and patient safety in our journey to bring the first device to treat small abdominal aortic aneurysms (AAAs) to market and to help hundred thousands of patients. 

Stay in touch

receive update emails a few times a year

stay in touch

Media Kit

further content about Angiolutions

Document title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Document title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Contact

Please leave your message here

contact